...
wve-img

Wave Life Sciences Ltd, Common Stock

WVE

NMQ

$13.09

-$1.36

(-9.41%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$2.05B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
994.51K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-1.21
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$3.5 L
$16.74 H
$13.09

About Wave Life Sciences Ltd, Common Stock

Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company's RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. It is developing WVE-006, a RNA editing oligonucleotide for the treatment of alpha-1 antitrypsin deficiency; siRNA clinical candidate for the treatment of obesity and other metabolic disorders; WVE-N531, a exon skipping oligonucleotide for the treatment of duchenne muscular dystrophy; and WVE-003, an antisense silencing oligonucleotide for the treatment of Huntington's disease (HD). The company has collaboration agreements with GlaxoSmithKline for the research, development, and commercialization of oligonucleotide therapeutics; Takeda Pharmaceutical Company Limited for the research, development, and commercialization of oligonucleotide therapeutics for disorders of the Central Nervous System; and Asuragen, Inc. for the development and potential commercialization of companion diagnostics for investigational allele-selective therapeutic programs targeting HD. Wave Life Sciences Ltd. was incorporated in 2012 and is based in Singapore. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameWVESectorS&P500
1-Week Return-16.94%-2.06%-0.55%
1-Month Return-0.39%-1.92%2.72%
3-Month Return134%-10.4%7.66%
6-Month Return124.17%-4.6%10.15%
1-Year Return185.08%4.06%27.53%
3-Year Return268.88%1.94%32.31%
5-Year Return-16.83%36.48%89.2%
10-Year Return-20%97.46%194.59%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue15.98M20.08M40.96M3.65M113.31M[{"date":"2019-12-31","value":14.11,"profit":true},{"date":"2020-12-31","value":17.72,"profit":true},{"date":"2021-12-31","value":36.15,"profit":true},{"date":"2022-12-31","value":3.22,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue175.43M124.17M121.88M10.11M9.21M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":70.78,"profit":true},{"date":"2021-12-31","value":69.47,"profit":true},{"date":"2022-12-31","value":5.77,"profit":true},{"date":"2023-12-31","value":5.25,"profit":true}]
Gross Profit(159.45M)(104.09M)(80.91M)3.65M104.10M[{"date":"2019-12-31","value":-153.17,"profit":false},{"date":"2020-12-31","value":-99.99,"profit":false},{"date":"2021-12-31","value":-77.73,"profit":false},{"date":"2022-12-31","value":3.51,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin(997.61%)(518.44%)(197.52%)100.00%91.88%[{"date":"2019-12-31","value":-997.61,"profit":false},{"date":"2020-12-31","value":-518.44,"profit":false},{"date":"2021-12-31","value":-197.52,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":91.88,"profit":true}]
Operating Expenses224.30M173.45M167.98M166.37M181.30M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":77.33,"profit":true},{"date":"2021-12-31","value":74.89,"profit":true},{"date":"2022-12-31","value":74.17,"profit":true},{"date":"2023-12-31","value":80.83,"profit":true}]
Operating Income(208.32M)(153.38M)(127.02M)(162.72M)(68.00M)[{"date":"2019-12-31","value":-20831700000,"profit":false},{"date":"2020-12-31","value":-15337700000,"profit":false},{"date":"2021-12-31","value":-12701600000,"profit":false},{"date":"2022-12-31","value":-16272000000,"profit":false},{"date":"2023-12-31","value":-6799600000,"profit":false}]
Total Non-Operating Income/Expense14.71M2.61M-3.15M-[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":17.75,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":21.41,"profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Pre-Tax Income(193.64M)(150.75M)(122.45M)(161.14M)(58.19M)[{"date":"2019-12-31","value":-19363800000,"profit":false},{"date":"2020-12-31","value":-15075100000,"profit":false},{"date":"2021-12-31","value":-12244900000,"profit":false},{"date":"2022-12-31","value":-16114200000,"profit":false},{"date":"2023-12-31","value":-5819000000,"profit":false}]
Income Taxes(14.14M)(841.00K)(204.00K)681.00K(677.00K)[{"date":"2019-12-31","value":-2076.65,"profit":false},{"date":"2020-12-31","value":-123.49,"profit":false},{"date":"2021-12-31","value":-29.96,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-99.41,"profit":false}]
Income After Taxes(179.50M)(149.91M)-(161.82M)-[{"date":"2019-12-31","value":-17949600000,"profit":false},{"date":"2020-12-31","value":-14991000000,"profit":false},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-16182300000,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income From Continuous Operations(193.64M)(149.91M)(122.25M)(161.82M)(57.51M)[{"date":"2019-12-31","value":-19363800000,"profit":false},{"date":"2020-12-31","value":-14991000000,"profit":false},{"date":"2021-12-31","value":-12224500000,"profit":false},{"date":"2022-12-31","value":-16182300000,"profit":false},{"date":"2023-12-31","value":-5751300000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(179.50M)(149.91M)(122.25M)(161.82M)(57.51M)[{"date":"2019-12-31","value":-17949600000,"profit":false},{"date":"2020-12-31","value":-14991000000,"profit":false},{"date":"2021-12-31","value":-12224500000,"profit":false},{"date":"2022-12-31","value":-16182300000,"profit":false},{"date":"2023-12-31","value":-5751300000,"profit":false}]
EPS (Diluted)(5.71)(3.98)(2.37)(2.13)(0.55)[{"date":"2019-12-31","value":-571,"profit":false},{"date":"2020-12-31","value":-398,"profit":false},{"date":"2021-12-31","value":-237,"profit":false},{"date":"2022-12-31","value":-213,"profit":false},{"date":"2023-12-31","value":-55,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

WVE
Cash Ratio 1.82
Current Ratio 1.90

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

WVE
ROA (LTM) -34.04%
ROE (LTM) -243.82%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

WVE
Debt Ratio Lower is generally better. Negative is bad. 0.60
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.40

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

WVE
Trailing PE NM
Forward PE NM
P/S (TTM) 38.27
P/B 14.48
Price/FCF NM
EV/R 32.97
EV/Ebitda NM
PEG NM

FAQs

What is Wave Life Sciences Ltd share price today?

Wave Life Sciences Ltd (WVE) share price today is $13.09

Can Indians buy Wave Life Sciences Ltd shares?

Yes, Indians can buy shares of Wave Life Sciences Ltd (WVE) on Vested. To buy Wave Life Sciences Ltd from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in WVE stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Wave Life Sciences Ltd be purchased?

Yes, you can purchase fractional shares of Wave Life Sciences Ltd (WVE) via the Vested app. You can start investing in Wave Life Sciences Ltd (WVE) with a minimum investment of $1.

How to invest in Wave Life Sciences Ltd shares from India?

You can invest in shares of Wave Life Sciences Ltd (WVE) via Vested in three simple steps:

  • Click on Sign Up or Invest in WVE stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Wave Life Sciences Ltd shares
What is Wave Life Sciences Ltd 52-week high and low stock price?

The 52-week high price of Wave Life Sciences Ltd (WVE) is $16.74. The 52-week low price of Wave Life Sciences Ltd (WVE) is $3.5.

What is Wave Life Sciences Ltd price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Wave Life Sciences Ltd (WVE) is

What is Wave Life Sciences Ltd price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Wave Life Sciences Ltd (WVE) is 14.48

What is Wave Life Sciences Ltd dividend yield?

The dividend yield of Wave Life Sciences Ltd (WVE) is 0.00%

What is the Market Cap of Wave Life Sciences Ltd?

The market capitalization of Wave Life Sciences Ltd (WVE) is $2.05B

What is Wave Life Sciences Ltd’s stock symbol?

The stock symbol (or ticker) of Wave Life Sciences Ltd is WVE

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top